awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45066717-3312C8F6-BFCE-4CF4-9963-0BCE33494B94
Q45066717-3312C8F6-BFCE-4CF4-9963-0BCE33494B94
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45066717-3312C8F6-BFCE-4CF4-9963-0BCE33494B94
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.
P2860
Q45066717-3312C8F6-BFCE-4CF4-9963-0BCE33494B94
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45066717-3312C8F6-BFCE-4CF4-9963-0BCE33494B94
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ba67953186f83db5fc64d00b28f3f20112c43ad
P2860
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial